NDC 58468-0426

Nexviazyme ngpt

Avalglucosidase Alfa

Nexviazyme ngpt is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genzyme Corporation. The primary component is Avalglucosidase Alfa.

• Product ID: 58468-0426_c7301aff-86cf-4e6d-8b7d-97b9d11502b4
• NDC: 58468-0426
• Product Type: Human Prescription Drug
• Proprietary Name: Nexviazyme ngpt
• Generic Name: Avalglucosidase Alfa
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-08-06
• Marketing Category: BLA /
• Application Number: BLA761194
• Labeler Name: Genzyme Corporation
• Substance Name: AVALGLUCOSIDASE ALFA
• Active Ingredient Strength: 100 mg/10mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 58468-0426-1

1 VIAL, SINGLE-DOSE in 1 CARTON (58468-0426-1) > 10 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2021-08-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details